Skip to main content
Zoom the image with the mouse

Health Care Policy and Regulation

by

ISBN: 9781461359326
List Price: $109.99
Special Offers Available
Free shipping on orders over $95
Buy one with 1% offer on sale price
Buy New
Hurry! Only left
Image coming soon
As low as $109.99

Health Care Policy and Regulation (9781461359326)

Springer

We can help you leverage the power of books

Customer Service

Connect with a dedicated account manager who is there every step of the way.

Price Match Guarantee

If you see better pricing elsewhere on your desired quantity, we will price match so you can be sure to get the best pricing.

Free Shipping

Enjoy free ground shipping on your order of $95 or more!

Brand New Guarantee

We only sell books that are brand new and protect that with a guarantee.

Customization

From author signatures to marketing inserts, custom packaging to brand stickers, we can help take your book marketing to the next level.

Learn more about ordering
Details
5 care reforms. Part II: Price Regulation The second partofthis volume examines the role ofprice regulation in controlling health care costs. It contains three chapters. In chapter seven, I examine the alternatives for regulating pharmaceutical prices. In chapter eight, Jack Hadley examines the impactofvarious forms ofhospital price regulation; while in chapter nine,MarkPaulyexaminestheroleofpriceregulation incontrollingphysician fees. Chapter seven focuses on the issue of regulating pharmaceutical prices. There are two key issues examined in this paper. First, is there a clear need for price regulation, and second, can price regulation work in this industry? In response to the first question, I come to the conclusion that the proponents ofprice regulation have not really proven their case. Although the financial returns in the pharmaceu­ tical industry have been slightly higher than expected during the 1970s and 1980s, there is not overwhelming evidence of"price gouging" or excessive profits on the part of the industry. In response to the second question, the answer is clearly no. The traditional approaches to price regulation will not have the intended affect of eliminating excess profits from the industry while maintaining the incentives for research and development. First, rate-of-return regulation, the most natural approach, would result in many adverse incentives-includingexcessive investment in research and developmentinorderto inflatetheratebaseused tocalculatedtheallowablereturns.

The book, Health Care Policy and Regulation (9781461359326) [Order Bulk Books, Wholesale, Quantity Discount] with ISBN# 9781461359326 in by may be ordered bulk quantities. Minimum orders start at copies.

Product details

Publisher: Springer US
Publisher: Springer US

GMA connects authors, speakers, and talent with the right people at the right time.

Learn More

Customer Reviews